Agaricoglycerides protect against hepatic ischemia/reperfusion injury by attenuating inflammatory response, oxidative stress, and expression of NF-κ B

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Zhao, Xiang Qian ^a   Liang, Bin ^a   Liu, Yang ^a   Huang, Xiao Qiang ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGARICOGLYCERIDE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIVER PROTECTIVE AGENT; MALONALDEHYDE; NATURAL PRODUCT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; INFLAMMATION; LIVER ISCHEMIA; LIVER PROTECTION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY;

EID: 84928739318     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/142736     Document Type: Article

References (22)

1. X.-D. Shen, F. Gao, B. Ke et al., "Inflammatory responses in a new mouse model of prolonged hepatic cold ischemia followed by arterialized orthotopic liver transplantation, " Liver Transplantation, vol. 11, no. 10, pp. 1273-1281, 2005.
2. N. Selzner, H. Rudiger, R. Graf, and P.-A. Clavien, "Protective strategies against ischemic injury of the liver, " Gastroenterology, vol. 125, no. 3, pp. 917-936, 2003.
3. A. Inoue, N. Kodama, andH. Nanba, "Effect ofmaitake (Grifola frondosa) D-fraction on the control of the Tlymph node Th-1/Th-2 proportion, " Biological and Pharmaceutical Bulletin, vol. 25, pp. 536-540, 2002.
4. B. C. Lee, J. T. Bae, H. B. Pyo et al., "Biological activities of the polysaccharides produced from submerged culture of the edible Basidiomycete Grifola frondosa, " Enzyme and Microbial Technology, vol. 32, no. 5, pp. 574-581, 2003.
5. N. A. Talpur, B. W. Echard, A. Y. Fan, O. Jaffari, D. Bagchi, and H. G. Preuss, "Antihypertensive and metabolic effects of whole maitake mushroom powder and its fractions in two rat strains, " Molecular and Cellular Biochemistry, vol. 237, no. 1-2, pp. 129-136, 2002.
6. M. Mayell, "Maitake extracts and their therapeutic potential, " Alternative Medicine Review, vol. 6, no. 1, pp. 48-60, 2001.
7. V. E. C. Ooi, "Hepatoprotective effect of some edible mushrooms, " Phytotherapy Research, vol. 10, no. 6, pp. 536-538, 1996.
8. M. Stadler, V. Hellwig, A. Mayer-Bartschmid, D. Denzer, B. Wiese, and N. Burkhardt, "Novel analgesic triglycerides from cultures of Agaricus macrosporus and other basidiomycetes as selective inhibitors of neurolysin, " Journal of Antibiotics, vol. 58, no. 12, pp. 775-786, 2005.
9. C. C. Han, "Antinociceptive activity of agaricoglycerides extracted frommyceliumof Ling Zhi or Reishi medicinalmushroom, Ganoderma lucidum (W. Curt.: Fr.) P. Karst. (Aphyllophoromycetideae), " International Journal of Medicinal Mushrooms, vol. 12, no. 3, pp. 273-278, 2010.
10. C. C. Han, "Antinociceptive activity of agaricoglycerides extracted frommyceliumof Ling Zhi or Reishi medicinalmushroom, Ganoderma lucidum (W. Curt.: Fr.) P. Karst. (Aphyllophoromycetideae), " International Journal of Medicinal Mushrooms, vol. 12, no. 3, pp. 273-278, 2010.
11. Y. Abe, I. N. Hines, G. Zibari et al., "Mouse model of liver ischemia and reperfusion injury: method for studying reactive oxygen and nitrogen metabolites in vivo, " Free Radical Biology and Medicine, vol. 46, no. 1, pp. 1-7, 2009.
12. K.-H. Moon, B. L. Hood, P. Mukhopadhyay et al., "Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion, " Gastroenterology, vol. 135, no. 4, pp. 1344-1357, 2008.
13. W. G. Land, "The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation, " Transplantation, vol. 79, no. 5, pp. 505-514, 2005.
14. M. M. Yeboah, X. Xue, B. Duan et al., "Cholinergic agonists attenuate renal ischemia-reperfusion injury in rats, " Kidney International, vol. 74, no. 1, pp. 62-69, 2008.
15. D. S. Pratt and M. M. Kaplan, "Evaluation of abnormal liverenzyme results in asymptomatic patients, " The New England Journal of Medicine, vol. 342, no. 17, pp. 1266-1271, 2000.
16. H. Ohkawa, N. Ohishi, and K. Yagi, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction, " Analytical Biochemistry, vol. 95, no. 2, pp. 351-358, 1979.
17. J. M. McCord, "The evolution of free radicals and oxidative stress, " The American Journal of Medicine, vol. 108, no. 8, pp. 652-659, 2000.
18. J. R. Klune and A. Tsung, "Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements, " The Surgical Clinics of North America, vol. 90, no. 4, pp. 665-677, 2010.
19. S. Srimal, N. Surolia, S. Balasubramanian, and A. Surolia, "Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A, " Biochemical Journal, vol. 315, part 2, pp. 679-686, 1996.
20. M. Kolb, P. J. Margetts, D. C. Anthony, F. Pitossi, and J. Gauldie, "Transient expression of IL-1 induces acute lung injury and chronic repair leading to pulmonary fibrosis, " Journal of Clinical Investigation, vol. 107, no. 12, pp. 1529-1536, 2001.
21. S. Kuboki, T. Okaya, R. Schuster et al., "HepatocyteNF-kappaB activation is hepatoprotective during ischemia-reperfusion injury and is augmented by ischemic hypothermia, " The American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 292, no. 1, pp. G201-G207, 2007.
22. E. Grillon, Y. Trioullier, A. Väth, J.-M. Verna, D. Blum, and H. Seegers, "Nuclear factor-B activation in permanent intraluminal focal cerebral ischemia in the rat, " Neuroscience Letters, vol. 288, no. 3, pp. 241-245, 2000.